Cargando…
A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response
Polymorphic parasite antigens are known targets of protective immunity to malaria, but this antigenic variation poses challenges to vaccine development. A synthetic MSP-1 Block 2 construct, based on all polymorphic variants found in natural Plasmodium falciparum isolates has been designed, combined...
Autores principales: | Cowan, Graeme J. M., Creasey, Alison M., Dhanasarnsombut, Kelwalin, Thomas, Alan W., Remarque, Edmond J., Cavanagh, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202563/ https://www.ncbi.nlm.nih.gov/pubmed/22073118 http://dx.doi.org/10.1371/journal.pone.0026616 |
Ejemplares similares
-
Merozoite surface protein 3.3C-specific antibodies block the intraerythrocytic development of Plasmodium falciparum and induce parasite apoptosis
por: Harris, Lvnne M, et al.
Publicado: (2012) -
Cohort study of the association of antibody levels to AMA1, MSP1(19), MSP3 and GLURP with protection from clinical malaria in Ghanaian children
por: Dodoo, Daniel, et al.
Publicado: (2008) -
A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila
por: Cowan, Graeme J. M., et al.
Publicado: (2014) -
Genetic Diversity of Polymorphic Marker Merozoite Surface Protein 1 (Msp-1) and 2 (Msp-2) Genes of Plasmodium falciparum Isolates From Malaria Endemic Region of Pakistan
por: Khan, Shahid Niaz, et al.
Publicado: (2021) -
Allelic diversity of MSP1 and MSP2 repeat loci correlate with levels of malaria endemicity in Senegal and Nigerian populations
por: Oboh, Mary A., et al.
Publicado: (2021)